[Umbilical cord blood from unrelated donor. An alternative to bone marrow transplantation].
Unrelated umbilical cord blood (UCB) as a source of haematopoietic stem/progenitor cells has been used for the first time in Sweden for allografting two boys (6 and 11 1/2 years old) with acute leukaemia in complete remission. Double class-II HLA-mismatch UCB units, from the Milan and New York cord blood banks, respectively, were used. Pre-transplant preparation consisted in fractionated total body irradiation in both cases, followed by cytoreductive high-dose cyclophosphamide for the 6-year-old with acute lymphocytic leukaemia (ALL) and fludarabine-melphalan for the 11 1/2-year-old with acute non-lymphocytic leukaemia (ANLL). Despite delayed haematopoietic recovery (probably due to HLA disparity) or reactivated cytomegalovirus infection in one boy, the immediate post-graft course was uneventful and extramedullary toxicity mild in both cases. Only transient acute graft-versus-host disease occurred, and complete donor chimerism was confirmed. Unfortunately, the out-come was unfavourable in both cases, the ANLL patient succumbing on day 96 due to pneumonia followed by multiorgan failure, and the ALL patient on day 140 due to combined medullar and central nervous system relapse. Although UCB transplantation needs further evaluation, it may contribute substantially to successful salvage procedures. Thus the introduction of cord blood banking in Sweden merits consideration.
Békássy
A
A
Sektionen för barnonkologi-hematologi, Barn- och ungdomscentrum, Universitetssjukhuset i Lund.
Sallerfors
B
B
Björk
P
P
Alvegård
T A
TA
Bengtsson
M
M
Carlson
K
K
Lönnerholm
G
G
Simonsson
B
B
D001771:Blood Banks; D001782:Blood Donors; D002648:Child; D017809:Fatal Outcome; D005312:Fetal Blood; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D000949:Histocompatibility Antigens Class II; D006650:Histocompatibility Testing; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D019172:Transplantation Conditioning / Q000379:methods
D000949:Histocompatibility Antigens Class II